New registry tracks Real-World success of synthetic bone grafts for back surgery
NCT ID NCT05329129
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This registry is following 450 adults undergoing spine fusion surgery who receive an OssDsign bone graft substitute. The goal is to see how well the bones fuse together and how patients' quality of life changes over time. It is an observational study, meaning no new treatment is being tested—just real-world data collected.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- OssDsign Catalyst (synthetic calcium phosphate bone graft substitute)
- What this could lead to
- If successful, this registry could provide real-world evidence on how well these bone grafts work for spine fusion, potentially guiding better surgical choices.
- What could go wrong
- This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may vary across patients and surgeons.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 450 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2022
- Expected to finish
-
Apr 2030
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients diagnosed with as a candidate for spinal fusion surgery
- Ages
-
21 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* The patient has been diagnosed as a candidate for spinal fusion surgery for which the surgeon has decided an OssDsign® bone graft is appropriate. * The patient is ≥21 years old. * The patient is, in the investigator's opinion, psychosocially, mentally, and physically able to fully comply with this protocol, including the post-operative regimen, required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent * The patient is willing and able to participate in post- operative clinical and radiographic follow up evaluations for 2 years. Exclusion Criteria: * Patients not meeting all of the inclusion criteria
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Degenerative disc disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
8 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Carle Foundation Hospital, NeuroScience Institute
COMPLETEDUrbana, Illinois, 61801, United States
-
Central Connecticut Neurosurgery and Spine
RECRUITINGNew Britian, Connecticut, 06051, United States
-
Community Health Partners Neuroscience
RECRUITINGFresno, California, 93720, United States
-
Foundation for Orthopaedic Research and Education
RECRUITINGTampa, Florida, 33607, United States
-
Memorial Orthopaedic Surgical Group
RECRUITINGLong Beach, California, 90806, United States
-
Minimally Invasive Spine Center of South Florida
RECRUITINGMiami, Florida, 33133, United States
-
Northeast Georgia Medical Center
ACTIVE_NOT_RECRUITINGGainesville, Georgia, 30501, United States
-
OrthoBethesda Research Foundation
ACTIVE_NOT_RECRUITINGBethesda, Maryland, 20817, United States
-
Orthopaedic Institute of Western Kentucky
COMPLETEDPaducah, Kentucky, 42001, United States
-
Orthopedic Associates of Hartford
ACTIVE_NOT_RECRUITINGHartford, Connecticut, 06102, United States
-
San Diego Neurosurgery
TERMINATEDSan Diego, California, 92024, United States
-
Texas Spine Consultants
NOT_YET_RECRUITINGAddison, Texas, 75001, United States
-
Twin Cities Orthopedics
ACTIVE_NOT_RECRUITINGEdina, Minnesota, 55435, United States
-
University Orthopedics Center
RECRUITINGState College, Pennsylvania, 16801, United States
-
Yale Center for Clinical Investigation, Yale School of Medicine
RECRUITINGNew Haven, Connecticut, 06519, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can ultrasound dye reveal spinal cord damage Mid-Surgery?
- A conversation before spine surgery could change how patients recover
- Can a new bone graft match the gold standard for spinal fusion?
- Can a nanotube surface help spinal bones fuse faster?
- Can a growth factor from donor bone improve spinal fusion?
- Can a One-Day mindset workshop stop chronic pain after back surgery?